Atrial Fibrillation
Conditions
Interventions
None listed
Sponsors
Tohoku Medical and Pharmaceutical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with a confirmed diagnosis of non-valvular atrial fibrillation who are able to attend outpatient follow-up visits. (2) Patients aged 20 years or older at the time of informed consent, regardless of sex. (3) Patients who have provided written informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with a confirmed diagnosis of mitral stenosis. (2) Patients with prosthetic heart valves (mechanical valves). (3) Patients who experienced a cardiovascular event (stroke, myocardial infarction, nonmyocardial infarction cardiovascular intervention, or heart failure requiring hospitalization) or bleeding requiring hospitalization within 1 month prior to enrollment. (4) Patients with a life expectancy of less than 1 year due to any underlying disease. (5) Patients with left atrial thrombus. (6) Patients who are unable to continue oral anticoagulant therapy. (7) Pregnant patients. (8) Patients with active malignancy. (9) Patients who are otherwise deemed inappropriate for study participation by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Absence of documented atrial fibrillation, atrial tachycardia, or atrial flutter lasting 30 seconds or longer without antiarrhythmic drug therapy, from 3 months after the procedure until the 12-month follow-up assessment. | — |
Countries
Japan
Contacts
Public ContactKumagai Koji
Tohoku Medical and Pharmaceutical University Department of Cardiovascular Medicine
Outcome results
None listed